Adial Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:ADIL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 5.04 M3.45 M6.8 M5.66 M6.67 M Total liabilities 975.86 K1.32 M1.21 M1.15 M1.4 M Total equity 4.07 M2.13 M5.59 M4.51 M5.28 M Total liabilities & shareholders' equities 5.04 M3.45 M6.8 M5.66 M6.67 M Total debt ————— Net debt —————

뉴스

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial, Molteni와 유럽 상업화 프레임워크 계약 체결

Adial Pharmaceuticals signs framework deal with Molteni for Europe

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals, FDA 정책 변화에 주가 상승

Adial Pharmaceuticals stock rises on FDA policy shift

AD04 임상, Adial, 단일 핵심 시험 경로 모색

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com

Adial Pharmaceuticals, 1대 25 역분할 발표 후 주가 급락

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split

애디얼 제약, 1대 25 역주식 병합 발표